Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

686
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
686
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

1.7K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.7K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Percutaneous Closure of Complex Fistulas Between the Left Main Coronary Artery and Right Atrium. Report of 3 Cases.

Revista espanola de cardiologia (English ed.)·2017
Same author

[Calculated pulmonary vascular resistance, is definitively a worthless variable. Current methods for a better definition].

Archivos de cardiologia de Mexico·2008
Same author

Predictors of mortality and adverse outcome in elderly high-risk patients undergoing percutaneous coronary intervention.

Archivos de cardiologia de Mexico·2007
Same author

[Acute coronary ischemic syndrome without ST elevation. Role of glycoprotein IIB/IIIA inhibitors and percutaneous coronary interventions].

Archivos de cardiologia de Mexico·2006
Same author

[Angiogenesis].

Archivos de cardiologia de Mexico·2003
Same journal

[The cardiorenometabolic syndrome as a new clinical paradigm in precision medicine].

Archivos de cardiologia de Mexico·2026
Same journal

Safety and efficacy of dual-axis rotational vs standard coronary angiography: meta-analysis.

Archivos de cardiologia de Mexico·2026
Same journal

Influence of socioeconomic status on ST-segment elevation myocardial infarction in Mexico.

Archivos de cardiologia de Mexico·2026
Same journal

Right-sided juxtaposition of the left atrial appendage with orifice origin in unhabitual location: case report.

Archivos de cardiologia de Mexico·2026
Same journal

Data-driven atherosclerotic plaque profiles from QAngio-CT associated with functional impairments assessed with PET-CT.

Archivos de cardiologia de Mexico·2026
Same journal

Establishment and evolution of a cardio-oncology clinic in a tertiary care cardiology hospital in Mexico.

Archivos de cardiologia de Mexico·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.2K

[Three-chamber pacemakers (ventricular resynchronization therapy)].

Marco Antonio Peña Duque1

  • 1Departamento de Hemodinámica, Instituto Nacional de Cardiología Ignacio Chávez, INCICH, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, 14080 México, D. F.

Archivos De Cardiologia De Mexico
|May 11, 2002
PubMed
Summary
This summary is machine-generated.

Congestive Heart Failure treatment improves quality of life but not mortality. Novel resynchronization therapy offers a new option for patients with conduction delays and asynchrony worsening ventricular function.

More Related Videos

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

16.6K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.4K

Related Experiment Videos

Last Updated: May 5, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

10.2K
Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
06:57

Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction

Published on: January 31, 2019

16.6K
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

2.4K

Area of Science:

  • Cardiology
  • Medical Technology

Context:

  • Congestive Heart Failure (CHF) patients, functional class III-IV, have limited treatment options.
  • Current treatments improve quality of life but do not reduce mortality.
  • Intraventricular conduction delay and interventricular asynchrony are common in CHF patients, worsening cardiac function.

Purpose:

  • To introduce resynchronization therapy as a novel treatment for specific Congestive Heart Failure patients.
  • To address the unmet need for mortality reduction in advanced CHF.

Summary:

  • Resynchronization therapy is presented as a potential intervention for Congestive Heart Failure patients experiencing intraventricular conduction delay and interventricular asynchrony.
  • This therapy aims to improve ventricular function in a subset of advanced CHF patients.

Impact:

  • Resynchronization therapy may offer a new therapeutic avenue for improving outcomes in selected Congestive Heart Failure patients.
  • Potential to improve ventricular function and address limitations of current CHF treatments.